Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Oct 5, 2020
Document Date
Oct 2, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
Crowley John F